Drug intelligence / Profile preview

Propolis Oromucoadhesive Film

Development stage: Unknown
Lead developer: The British University in Egypt
Modality: Small Molecules
Administration: Buccal

Overview

Propolis Oromucoadhesive Film is a pharmaceutical formulation designed for topical application to the oral mucosa, specifically investigated for the treatment of Recurrent Aphthous Ulcers (RAU). The film incorporates niosomal propolis, a natural resinous substance collected by bees, known for its anti-inflammatory, antimicrobial, and wound-healing properties. The mucoadhesive nature of the film ensures prolonged contact with the ulcerated area, facilitating sustained release of propolis and promoting local therapeutic effects.

Other names: Niosomal Propolis as Oromucoadhesive Filmpropolis mucoadhesive film

Beyond the preview

Go deeper on Propolis Oromucoadhesive Film.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Propolis Oromucoadhesive Film.

Explore the full profile